Macerich (MAC) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Werte in diesem Artikel
In its upcoming report, Macerich (MAC) is predicted by Wall Street analysts to post quarterly earnings of $0.40 per share, reflecting a decline of 9.1% compared to the same period last year. Revenues are forecasted to be $219.69 million, representing a year-over-year increase of 0.7%.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.Bearing this in mind, let's now explore the average estimates of specific Macerich metrics that are commonly monitored and projected by Wall Street analysts.According to the collective judgment of analysts, 'Leasing Revenue- Minimum rents' should come in at $127.90 million. The estimate suggests a change of +3.3% year over year.Analysts' assessment points toward 'Management Companies revenues' reaching $7.31 million. The estimate indicates a year-over-year change of -1.8%.Analysts expect 'Leasing Revenue- Tenant recoveries' to come in at $59.69 million. The estimate indicates a change of +2% from the prior-year quarter.Based on the collective assessment of analysts, 'Leasing Revenue- Percentage rents' should arrive at $7.59 million. The estimate indicates a year-over-year change of -7.6%.It is projected by analysts that the 'Depreciation and amortization' will reach $68.89 million. The estimate compares to the year-ago value of $70.76 million.View all Key Company Metrics for Macerich here>>>Shares of Macerich have demonstrated returns of +5.8% over the past month compared to the Zacks S&P 500 composite's -0.5% change. With a Zacks Rank #4 (Sell), MAC is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Macerich Company (The) (MAC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Macerich
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Macerich
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Macerich Co.
Analysen zu Macerich Co.
Datum | Rating | Analyst | |
---|---|---|---|
20.04.2018 | Macerich Outperform | BMO Capital Markets | |
03.01.2018 | Macerich Sector Perform | RBC Capital Markets | |
15.09.2017 | Macerich Market Perform | BMO Capital Markets | |
27.03.2017 | Macerich Equal Weight | Barclays Capital | |
07.02.2017 | Macerich Hold | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
20.04.2018 | Macerich Outperform | BMO Capital Markets | |
15.09.2017 | Macerich Market Perform | BMO Capital Markets | |
07.02.2017 | Macerich Hold | Stifel, Nicolaus & Co., Inc. | |
07.11.2016 | Macerich Buy | Mizuho | |
06.05.2016 | Macerich Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2018 | Macerich Sector Perform | RBC Capital Markets | |
27.03.2017 | Macerich Equal Weight | Barclays Capital | |
23.01.2017 | Macerich Hold | Canaccord Adams | |
14.04.2016 | Macerich Neutral | Mizuho | |
03.11.2015 | Macerich Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Macerich Co. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen